Generex Subsidiary NuGenerex Diagnostics Announces CE-Mark Certification for its Rapid Point-of-Care Express II Syphilis Treponemal Assay

Stock Information for Generex Biotechnology

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Generex Biotechnology

Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C.
Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th
Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors
Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing
Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million
Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting
USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY
KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.